Eli Lilly offers Zepbound vials at half price for more affordable anti-obesity drug option.
Eli Lilly, a US pharmaceutical company, is now selling its weight-loss drug, Zepbound, in vials at approximately half the price of the original injection pens for certain doses. The move comes in response to high demand and aims to provide a more affordable option for anti-obesity drug users, especially those whose insurance does not cover such medications. The vials will be offered through Lilly's online service, LillyDirect, and contain detailed instructions for safe drug administration.
August 27, 2024
456 Articles